| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
254,036,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$22.93 - $22.93 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Rodriguez Rama Francisco |
Senior V.P., Tech. OperationsO |
• – – |
2013-02-04 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
22,929 |
|
- |
|
| Van Zoonen Marinus Johannes |
President, Europe/Intl & Mkt. |
• – – |
2013-02-01 |
4 |
S |
$14.18 |
$195,517 |
D/D |
(13,790) |
132,235 |
|
- |
|
| Halstead Michael |
Senior V.P., Corp. Development |
• – – |
2013-02-01 |
4 |
S |
$14.18 |
$14,150 |
D/D |
(998) |
38,902 |
|
- |
|
| Ellman Herman |
Senior V.P., Clinical Devel. |
• – – |
2013-02-01 |
4 |
S |
$14.18 |
$14,320 |
D/D |
(1,010) |
168,110 |
|
- |
|
| Cross Leland H |
Senior V.P., Tech. Operations |
• – – |
2013-02-01 |
4 |
S |
$14.18 |
$11,456 |
D/D |
(808) |
191,233 |
|
- |
|
| Howard Alvin D |
Sr. V.P., Regulatory Affairs |
• – – |
2013-02-01 |
4 |
S |
$14.18 |
$14,320 |
D/D |
(1,010) |
86,714 |
|
- |
|
| Gilligan Claire A |
Senior V.P., Quality |
• – – |
2013-02-01 |
4 |
S |
$14.18 |
$19,523 |
D/D |
(1,377) |
65,561 |
|
- |
|
| Fenton Andrew |
Senior V.P., CIO |
• – – |
2013-02-01 |
4 |
S |
$14.18 |
$14,121 |
D/D |
(996) |
94,649 |
|
- |
|
| Fuhrmann Rochelle |
Senior V.P., Finance |
• – – |
2013-02-01 |
4 |
S |
$14.18 |
$14,150 |
D/D |
(998) |
43,571 |
|
- |
|
| Boissonneault Roger M |
CEO & President |
• • – |
2013-02-01 |
4 |
S |
$14.18 |
$129,376 |
D/D |
(9,125) |
2,222,156 |
|
- |
|
| Herendeen Paul |
Exec. V.P. and CFO |
• – – |
2013-02-01 |
4 |
S |
$14.18 |
$40,266 |
D/D |
(2,840) |
101,543 |
|
- |
|
| Van Zoonen Marinus Johannes |
President, Europe/Intl & Mkt. |
• – – |
2013-01-30 |
4 |
S |
$13.38 |
$31,621 |
D/D |
(2,215) |
146,025 |
|
- |
|
| Fuhrmann Rochelle |
Senior V.P., Finance |
• – – |
2013-01-30 |
4 |
S |
$13.38 |
$3,774 |
D/D |
(282) |
44,569 |
|
- |
|
| Howard Alvin D |
Sr. V.P., Regulatory Affairs |
• – – |
2013-01-30 |
4 |
S |
$13.38 |
$7,910 |
D/D |
(591) |
87,724 |
|
- |
|
| Ellman Herman |
Senior V.P., Clinical Devel. |
• – – |
2013-01-30 |
4 |
S |
$13.38 |
$7,843 |
D/D |
(586) |
169,120 |
|
- |
|
| Halstead Michael |
Senior V.P., Corp. Development |
• – – |
2013-01-30 |
4 |
S |
$13.38 |
$4,283 |
D/D |
(320) |
39,900 |
|
- |
|
| Cross Leland H |
Senior V.P., Tech. Operations |
• – – |
2013-01-30 |
4 |
S |
$13.38 |
$6,224 |
D/D |
(465) |
192,041 |
|
- |
|
| Fenton Andrew |
Senior V.P., CIO |
• – – |
2013-01-30 |
4 |
S |
$13.38 |
$4,698 |
D/D |
(351) |
95,645 |
|
- |
|
| Gilligan Claire A |
Senior V.P., Quality |
• – – |
2013-01-30 |
4 |
S |
$13.38 |
$6,545 |
D/D |
(489) |
66,938 |
|
- |
|
| Herendeen Paul |
Exec. V.P. and CFO |
• – – |
2013-01-30 |
4 |
S |
$13.38 |
$29,552 |
D/D |
(2,208) |
104,383 |
|
- |
|
| Boissonneault Roger M |
CEO & President |
• • – |
2013-01-30 |
4 |
S |
$13.38 |
$113,363 |
D/D |
(8,470) |
2,231,281 |
|
- |
|
| Cross Leland H |
Senior V.P., Tech. Operations |
• – – |
2013-01-22 |
4 |
S |
$13.50 |
$11,326 |
D/D |
(839) |
192,506 |
|
- |
|
| Howard Alvin D |
Sr. V.P., Regulatory Affairs |
• – – |
2013-01-22 |
4 |
S |
$13.50 |
$16,497 |
D/D |
(1,222) |
88,315 |
|
- |
|
| Ellman Herman |
Senior V.P., Clinical Devel. |
• – – |
2013-01-22 |
4 |
S |
$13.50 |
$15,741 |
D/D |
(1,166) |
169,706 |
|
- |
|
| Fenton Andrew |
Senior V.P., CIO |
• – – |
2013-01-22 |
4 |
S |
$13.50 |
$8,383 |
D/D |
(621) |
95,996 |
|
- |
|
380 Records found
|
|
Page 4 of 16 |
|
|
